[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Atopic dermatitis Global Clinical Trials Review, H2, 2019

December 2019 | 716 pages | ID: ABFD6EC322B3EN
GlobalData

US$ 2,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Atopic dermatitis Global Clinical Trials Review, H2, 2019

SUMMARY

GlobalData's clinical trial report, “Atopic dermatitis Global Clinical Trials Review, H2, 2019' provides an overview of topic dermatitis clinical trials scenario. This report provides top line data relating to the clinical trials on topic dermatitis . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

REASONS TO BUY
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Report Guidance
GlobalData Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Atopic Dermatitis (Atopic Eczema) to Dermatology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Atopic Dermatitis (Atopic Eczema) to Dermatology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Atopic Dermatitis (Atopic Eczema)
Nov 14, 2019: Dermira presents new scientific research findings from the lebrikizumab program at Leading International Itch Conference
Nov 12, 2019: XBiotech announces first patient enrolled in placebo-controlled clinical study evaluating its anti-IL-1 therapy Bermekimab in patients with Atopic Dermatitis (Eczema)
Nov 10, 2019: Nektar Therapeutics presents data from first-in-human phase 1a study on novel T regulatory cell stimulator, NKTR-358 at 2019 Annual Meeting of the American College of Rheumatology
Nov 08, 2019: AnaptysBio reports Etokimab ATLAS phase 2b clinical trial in moderate-to-severe atopic dermatitis fails to meet primary endpoint
Nov 06, 2019: Arena Pharmaceuticals presented new data highlighting the human mass balance and metabolism profile of Etrasimod at AAPS
Nov 04, 2019: Ichnos Sciences provides update on its Atopic Dermatitis drug candidate ISB 830
Nov 04, 2019: Ichnos Sciences announces completion of enrollment of phase 2b trial for Investigational Therapy - ISB 830
Oct 28, 2019: MorphoSys: MOR106 clinical development in atopic dermatitis stopped
Oct 28, 2019: Arena Pharmaceuticals Announces First Subject Dosed in ADVISE Phase 2 Trial Evaluating Etrasimod in Atopic Dermatitis
Oct 23, 2019: RAPT Therapeutics announces initiation of first-in-human phase 1 study of RPT193
Oct 23, 2019: BTX 1503 acne phase 2 study results presentation
Oct 23, 2019: AnaptysBio: Promising therapy for common form of eczema identified in early-stage trial
Oct 22, 2019: ASLAN Pharmaceuticals enrolls first patient in proof-of-concept study for ASLAN004 targeting Atopic Dermatitis
Oct 17, 2019: Dermira presents data from phase 2b study of Lebrikizumab in patients with Atopic Dermatitis at Fall Clinical Dermatology Conference
Oct 14, 2019: Pfizer’s JAK1 inhibitor performs well in atopic dermatitis
Oct 10, 2019: Dermira launches Phase III lebrikizumab programme
Oct 10, 2019: Dermira to present data from phase 2b study of Lebrikizumab in patients with atopic dermatitis at Fall Clinical Dermatology Conference
Oct 10, 2019: Galderma advances phase 3 clinical study with Nemolizumab in moderate-to-severe atopic dermatitis
Oct 09, 2019: AbbVie announces new data from Upadacitinib at the 28th European Academy of Dermatology and Venereology (EADV) Congress
Oct 08, 2019: Innovation Pharmaceuticals cites recent academic literature showing host defense proteins at Cutting-Edge of Medicine for Multiple Diseases
Oct 08, 2019: Lilly presents on Olumiant at the 28th Annual European Academy of Dermatology and Venereology (EADV) Congress
Oct 07, 2019: Nektar Therapeutics announces initiation of two clinical studies of novel T regulatory cell stimulator NKTR-358 (LY3471851) in patients with psoriasis and atopic dermatitis
Sep 27, 2019: Pfizer announces positive top-line results from second pivotal phase 3 study of investigational Oral JAK1 candidate, Abrocitinib, in patients Aged 12 and older with moderate to severe Atopic Dermatitis
Sep 27, 2019: Health Canada approves Dupixent™ as the first biologic for the treatment of adolescents with moderate-to-severe atopic dermatitis
Sep 17, 2019: Arena pharmaceuticals to present new preclinical atopic dermatitis data for Etrasimod at the European Society for Dermatologic Research Annual Meeting
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Source

LIST OF TABLES

Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials by Region, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Europe, Top Five Countries, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, North America, Top Countries, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019*
Proportion of Atopic Dermatitis (Atopic Eczema) to Dermatology Clinical Trials, G7 Countries (%), 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
Proportion of Atopic Dermatitis (Atopic Eczema) to Dermatology Clinical Trials, E7 Countries (%), 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials by Phase, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials In Progress by Phase 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials by Trial Status, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, by End Point Status, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
Atopic Dermatitis (Atopic Eczema) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*

LIST OF FIGURES

Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials by Region (%), 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, North America, Top Countries (%), 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019*
Proportion of Atopic Dermatitis (Atopic Eczema) to Dermatology Clinical Trials, G7 Countries (%), 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
Proportion of Atopic Dermatitis (Atopic Eczema) to Dermatology Clinical Trials, E7 Countries (%), 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials by Phase (%), 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials In Progress by Phase, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials by Trial Status, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, by End Point Status, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
Atopic Dermatitis (Atopic Eczema) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*
GlobalData Methodology

COMPANIES MENTIONED

Novartis AG
Pfizer Inc
Sanofi
Regeneron Pharmaceuticals Inc
LEO Foundation
Astellas Pharma Inc
GlaxoSmithKline Plc
Eli Lilly and Co
Bayer AG
Galderma SA


More Publications